Holen Sie sich die Stockscreener-App
1.60
5.96%
0.09
Handel nachbörslich:
1.60
Schlusskurs vom Vortag:
$1.51
Offen:
$1.53
24-Stunden-Volumen:
258.11K
Relative Volume:
0.84
Marktkapitalisierung:
$49.91M
Einnahmen:
$1.05M
Nettoeinkommen (Verlust:
$-48.82M
KGV:
-0.8743
EPS:
-1.83
Netto-Cashflow:
$-47.49M
1W Leistung:
+0.00%
1M Leistung:
+5.26%
6M Leistung:
+45.45%
1J Leistung:
-20.00%
1-Tages-Spanne:
$1.49
$1.64
1-Wochen-Bereich:
$1.39
$1.64
52-Wochen-Spanne:
$1.06
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Firmenname
Actinium Pharmaceuticals Inc
Sektor
Branche
Telefon
646-767-3870
Adresse
275 Madison Avenue, 7th Floor, New York, NY
Vergleichen Sie ATNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.60 | 47.11M | 1.05M | -48.82M | -47.49M | -1.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-07 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-21 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Eingeleitet | B. Riley Securities | Buy |
| 2020-11-05 | Eingeleitet | Alliance Global Partners | Buy |
| 2017-12-06 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Fortgesetzt | ROTH Capital | Buy |
| 2017-09-14 | Eingeleitet | Maxim Group | Buy |
| 2016-08-25 | Eingeleitet | ROTH Capital | Buy |
| 2016-02-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2014-10-01 | Eingeleitet | MLV & Co | Buy |
| 2014-07-22 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten
Will Actinium Pharmaceuticals Inc. rebound enough to break evenRisk Management & Smart Swing Trading Techniques - Newser
Actinium Pharmaceuticals Inc. Price Targets Raised After ReboundWeekly Investment Recap & Community Consensus Trade Signals - beatles.ru
How to track smart money flows in Actinium Pharmaceuticals Inc.July 2025 Weekly Recap & Daily Profit Focused Stock Screening - Newser
How to manage a losing position in Actinium Pharmaceuticals Inc.Global Markets & High Win Rate Trade Alerts - Newser
What institutional flow reveals about Actinium Pharmaceuticals Inc.Real Market Tracker with Price Action Tools - Newser
What moving averages say about Actinium Pharmaceuticals IncFree Swing Trade With Risk Management - Newser
Is Actinium Pharmaceuticals Inc. showing signs of accumulationTrend Following Ideas with Volume Confirmation - Newser
Is Actinium Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Free Secure Return Focused Investment Plan - Newser
Analyzing drawdowns of Actinium Pharmaceuticals Inc. with statistical toolsPredictive Analytics for Equity Growth Potential - Newser
Can Actinium Pharmaceuticals Inc. hit a new high this monthFree Market Surge Signal for Swing Traders - Newser
Visualizing Actinium Pharmaceuticals Inc. stock with heatmapsFree Stock Selection With High Accuracy - Newser
Can technical indicators confirm Actinium Pharmaceuticals Inc.’s reversalFree Short Term Trading Opportunity Watch - Newser
Has Actinium Pharmaceuticals Inc. formed a bullish divergenceNeural Model for Stock Price Movement - Newser
Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionFree Oversold Recovery Opportunity Stocks - Newser
What’s the recovery path for long term holders of Actinium Pharmaceuticals Inc.Free AI Driven Buy Alert Trade Blueprint - Newser
Actinium Pharmaceuticals Inc. stock daily chart insightsFree Earnings Play Trade Plan With Alerts - Newser
Visual analytics tools that track Actinium Pharmaceuticals Inc. performanceAsset Safety Selection Using Quantitative Analysis - Newser
Actinium Pharmaceuticals Inc.’s volatility index tracking explainedWeekly Trend Screener with Momentum Picks - Newser
Analyzing Actinium Pharmaceuticals Inc. with risk reward ratio chartsDividend Strategy Summary With 10-Year Outlook - Newser
Published on: 2025-08-09 00:23:20 - Newser
Actinium: Q2 Earnings Snapshot - San Francisco Chronicle
Financial Contrast: Gemini Therapeutics (NASDAQ:GMTX) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Can machine learning forecast Actinium Pharmaceuticals Inc. recoveryShort Term Profit Strategy with Entry Cues - Newser
What moving averages say about Actinium Pharmaceuticals Inc.AI Intraday Market Movement Prediction Tool - Newser
Is it time to cut losses on Actinium Pharmaceuticals Inc.Volatility Analysis and Entry Risk Mapping - Newser
How strong is Actinium Pharmaceuticals Inc. company’s balance sheetFree Buy/Sell Signal Notifications - Jammu Links News
What are the latest earnings results for Actinium Pharmaceuticals Inc.Consistent triple-digit returns - Jammu Links News
What analysts say about Actinium Pharmaceuticals Inc. stockSuperior returns - Jammu Links News
What is the dividend policy of Actinium Pharmaceuticals Inc. stockHigh-performance stocks for savvy investors - Jammu Links News
Is it the right time to buy Actinium Pharmaceuticals Inc. stockAccelerated capital growth - Jammu Links News
What institutional investors are buying Actinium Pharmaceuticals Inc. stockAchieve breakthrough gains with expert advice - Jammu Links News
How does Actinium Pharmaceuticals Inc. compare to its industry peersGet daily expert analysis on top stocks - Jammu Links News
When is Actinium Pharmaceuticals Inc. stock expected to show significant growthAchieve consistent double-digit returns - Jammu Links News
What is Actinium Pharmaceuticals Inc. company’s growth strategyExceptional growth trajectory - jammulinksnews.com
What are analysts’ price targets for Actinium Pharmaceuticals Inc. in the next 12 monthsInvest confidently with market-leading analysis - Jammu Links News
Is Actinium Pharmaceuticals Inc. a growth stock or a value stockUnprecedented market success - Jammu Links News
What makes Actinium Pharmaceuticals Inc. stock price move sharplyDaily Technical Forecast for Quick Gains - Newser
Key External Factors That Drive Actinium Pharmaceuticals Inc. Stock Price MovementsReal Time Growth Signal with Smart Setup - Newser
Actinium Pharmaceuticals shares rise 5.73% intraday after presenting positive data for ATNM-400 in prostate cancer treatment. - AInvest
Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficac - PR Newswire
Will Actinium Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsFree Risk Managed Intraday Trade Alerts - Newser
Actinium Pharmaceuticals Inc. recovery potential after sell offWatchlist Generator for Smart Money Signals - Newser
Published on: 2025-07-31 05:11:29 - metal.it
What’s next for Actinium Pharmaceuticals Inc. stock priceTrade Scanner With Buy Zone Alerts Flagged - metal.it
How Actinium Pharmaceuticals Inc. stock performs during market volatilityShort Term Alpha Signals Insight - beatles.ru
Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):